compromise between benefits and harm. The present review details the relationship between renal IRI and hypothermia, describing the pathophysiology of IRI and hypothermic protection through experimental evidence. Although experimental models of renal IRI are a valuable tool for understanding the pathophysiology of renal ischaemia-reperfusion, the clinical transfer of experimental results has several limitations, particularly because of anatomical and physiological differences. In this review limitations of animal models but also hypothermia as a strategy to protect the kidney from IRI are discussed. We also attempt to describe three clinical scenarios where hypothermia is used in clinical settings of IRI: transplantation, deceased donors and post-cardiac arrest.
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I N T R O D U C T I O N
Cellular damage after reperfusion of ischaemic tissue is defined as ischaemia-reperfusion injury (IRI) [1] . Although restoration of blood flow to an ischaemic organ is essential to prevent irreversible cellular injury, reperfusion may augment tissue injury in excess of that produced by ischaemia alone. Hypothermia is a protective manoeuvre against ischaemic injury, if applied during the reperfusion period. In kidney transplantation, almost 30% of delayed graft function (DGF) is attributable to IRI, in which a significant portion of damage occurs during and following the reperfusion [2] . Even though cooling can help to decrease the deleterious effects of ischaemia, the consequences are not exclusively beneficial [3] . Encouraging results of a randomized controlled trial (RCT) suggested the decrease in whole-body temperature in deceased organ donors as a relatively safe and presumably easy to deliver intervention, with a meaningful impact on graft outcomes [4] . However, if donation after cardiac death (DCD) is performed in order to increase the numbers of available organs in the category of deceased organ donors, it is probable that a future use of whole-body cooling in these donors could be useful in limiting the whole-body ischaemia-reperfusion syndrome after cardiac arrest (CA). Although there is significant laboratory evidence supporting the efficacy of hypothermia in preserving organ function [5, 6] , the cooling of the whole body for neurological protection in CA patients is challenged by a series of trials that show no benefit [7, 8] , and few studies have investigated the benefits on kidney outcomes. The present review details the relationship between renal IRI and hypothermia, describing the pathophysiology of IRI and hypothermic protection through experimental evidence. Although experimental models of IRI are a valuable tool for understanding the pathophysiology of renal ischaemia-reperfusion, the clinical translation/application of experimental results has several limitations, particularly because of anatomical and physiological differences. In this review limitations of animal models but also hypothermia as a strategy to protect the kidney from IRI are discussed. We also attempt to describe three clinical scenarios where hypothermia is used in clinical settings of IRI: transplantation, deceased donors and postcardiac arrest.
P A T H O P H Y S I O L O G Y O F I S C H A E M I A -R E P E R F U S I O N I N J U R Y
In hospitalized patients, renal IRI is more frequently due to transient or prolonged renal hypoperfusion [pre-renal acute kidney injury (AKI)]. However, it may be also due to transient occlusion of the renal artery in suprarenal aortic aneurysm repair, nephrectomy and renal transplantation [9, 10] . The IRI is characterized by blood flow interruption and a vascular reperfusion period (Figure 1 ). During renal blood flow (RBF) interruption, the reduction in medullary blood flow and the resultant decrease of glucose and oxygen delivery to the tubular structures causes an imbalance between delivery and demand [11] . Cells are forced to maintain adenosine 5 0 -triphosphate (ATP) production by anaerobic glycolysis using glycogen stores and the remaining glucose in the surrounding tissue fluid [11] . This leads to local tissue acidosis [12] . The ATP depletion is followed by events that severely disturb the tubular homoeostasis such as the increase of cytoplasmic calcium load, which activates proteases, phospholipases and caspases [13] , with cellular accumulation of hypoxanthine and reactive oxygen species (ROS) [13] . Hypoxia, glucose depletion, acidosis and ROS production contribute to apoptosis and active necrosis. An early structural manifestation of ischaemia is the loss of cell polarity with decreased reabsorption of sodium and water from the tubular lumen [14] . Due to diminished sodium reabsorption, distal segments of the tubule are activated to release signals that induce constriction of the vasa afferentia (tubuloglomerular feedback) [9] . Following IRI both recovery and additional injury events occur that are ATP-and perfusion-dependent. A phenomenon called the pH paradox may occur during the reperfusion phase: if the reperfusion of ischaemic cells occurs in the presence of an acidotic pH, the cell killing is abrogated. On the contrary, the rise in intracellular pH during reperfusion causes cell killing [15] . Reperfusion induces Ca 2þ delivery by depleted cells, producing Ca 2þ overload and post-ischaemic injury through multiple pathways (e.g. mitochondrial dysfunction, increased ROS formation and phospholipase activation) [16] . The length of reperfusion is important for the prevention or mitigation of ischaemic injury, and for therapeutic implications as well. A delay of restoration of renal function is due to interstitial inflammation and interstitial microvasculopathy. Tubular epithelial and vascular endothelial cells release a diverse range of pro-inflammatory cytokines, inducing and perpetuating inflammation [17] . Post-ischaemic renal inflammation may contribute to microvasculopathy characterized by endothelial cell swelling that can lead to prolonged ischaemia and slower reperfusion, even if the primary cause has been eliminated: this is defined as the no-reflow phenomenon [18] . Post-ischaemic microvasculopathy is related to the risk of developing chronic renal impairment, and it can potentially serve as a therapeutic target [19] . Renal IRI and hypothermia are widely explored in our experimental model that will be the topic of the next section.
Animal models of renal IRI have been instrumental in defining the pathophysiology of remote organ dysfunction after AKI by reducing the complexity and experimental limitations associated with human studies [20] . Unfortunately, different vascular properties of the renal medulla may contribute to the variability in the pathophysiology of ischaemic AKI among different animals and in the capability to replicate the findings in human AKI: for example, in rats prolonged hypotension does not cause IRI [21] . Although this model is not ideal, it is widely used to study both injury and recovery phases of AKI. Caution is necessary in the extrapolation of experimental data because renal structure and function varies between species. Porcine kidney is most similar to the human kidney: the multilobular structure, the physiology and the immune systems provide a basic knowledge of graft recovery and inflammatory physiopathology through in vivo studies [22] . Models of hypoxic/ischaemic AKI include in vivo warm and cold ischaemia and reperfusion models. Warm ischaemia-reperfusion (WIR) injury is characterized by complete interruption of RBF by clamping of the renal arteries for a determined period of time (20-60 min) . Tissue hypoxia is the principal pathophysiological insult: ROS production during reperfusion contributes to endothelial dysfunction, alteration of outer medullary microcirculation, inflammation and tubular injury. The damage appears at the beginning in the cortico-medullary junction (the outer stripe of the outer medulla) [23] . Injury will start in the proximal tubule, extend to the medullary ray and, finally, involve the proximal convoluted tubules in the cortical labyrinth. After 20-30 min of ischaemia, injury is focal and limited; after 50-60 min, the damage encompasses most of the renal parenchyma: the outer medulla becomes infarcted, and injury extends to the cortex involving both proximal and convoluted segments [24] . WIR is the most extensively used animal model [23] . Cold ischaemia-warm reperfusion (CIR) injury is the model rarely used in studies of experimental AKI: the kidney is removed, flushed and kept at low temperature under conditions similar to those in cold preservation for transplantation. In this model, the preservation of the proximal tubule is better and the distal nephron injury is more prominent upon reperfusion. Studies have suggested that FIGURE 1: Ischaemia-reperfusion injury. The blood flow interruption causes an imbalance between O 2 delivery and demand: the consequent hypoxia, glucose depletion, acidosis and ROS production contribute to cell death. In addition, tubular epithelial and vascular endothelial cells release pro-inflammatory cytokines (interstitial inflammation) that are also responsible for endothelial cell swelling with a consequent prolonged ischaemia and slower reperfusion (interstitial microvasculopathy). During reperfusion, the restoration of pH induces Ca 2þ delivery by depleted cells, producing Ca 2þ overload and increased oxygen-derived free radical formation that both contribute to an inflammatory cascade and cell injury. ATP, adenosine triphosphate; Caþþ, calcium ions; DNA, deoxyribonucleic acid; GLC, glucose; ROS, reactive oxygen species; IRI, ischaemia-reperfusion injury; IL, interleukin; IFN, interferon; TNF, tumour necrosis factor.
the inner stripe and papillary damage (cold ischaemia) and the outer stripe and cortical injury (warm ischaemia) occur if the cold ischaemia time is prolonged [23] . Experimental examinations performed in dogs analysing renal hypothermia to prevent ischaemic damage showed a reduction of perfusion probably due to cold-induced vasoconstriction with intact tubular function because of the protective mechanism of hypothermia. Shirmer and Walton [25] investigated in dog kidneys the renal effects of hypothermia, showing that, with local cooling, renal function would only be temporarily depressed and irreversible damage could be limited [23] . Table 1 gives ischaemia-related events influenced by hypothermia. A recent animal model was performed to evaluate the role of predetermined ranges of local hypothermia [637 C, 26 C, 15 C and 4 C] on oxidative-stress markers. Results showed an increase in catalase during deep hypothermia (4 C), suggesting the association of this level of temperature to a higher anti-oxidative effect with a decrease in free radical production, although tissue protection was not observed [6] . Experimental studies have also investigated the effect of body temperature on renal susceptibility to ischaemic injury, showing that body temperature dramatically accentuates hypoxic injury: hyperthermia potentiated ischaemic renal injury, whereas hypothermia conferred protection [26] . Minimal temperature changes during renal ischaemia may alter functional and morphological outcomes [27] . Hence, in animals hypothermia is able to reduce the risk of renal failure after renal IRI [28] .
K I D N E Y T R A N S P L A N T A T I O N A N D D E C E A S E D D O N O R S
In kidney transplantation, IRI is the one of most important non-immunologic factors responsible for DGF and late allograft dysfunction. IRI activates different programmes of cell death: necrosis, apoptosis or autophagy-associated cell death. Some authors have hypothesized that autophagy is one of the principal protective tools adopted by injured cells as it is a protective response to pathological injuries and is reliable for improving graft outcome [29] . In transplant, several factors participated in the ischaemic pathological process: (i) clamping of the renal artery in the allograft from a living related donor; (ii) cold ischaemia in allograft kidney storage; and (iii) haemodynamic disturbances with impairment of blood flow in the allograft from a deceased donor [30] . After surgical removal, the kidney is preserved in hypothermic solutions designed to allow effective organ flush to remove blood, cool the organ, and minimize the negative effects of ischaemia and hypothermia; those solutions are defined as intracellular (high potassium concentration) and extracellular (high sodium concentration). The common composition of hypothermic solutions is presented in Table 2 . The resulting equilibrium between intravascular, interstitial and intracellular fluid compartments prevents cellular oedema, maintaining membrane function. Organs are stored at 4 C based on the principle that metabolism is slowed by almost 2-fold for each 10 C drop in temperature (static preservation method) [31] . An alternative to cold storage is hypothermic machine perfusion (HMP) [31] , which allows a continual flush of the microcirculation, preventing the accumulation of waste products, sustaining a higher metabolic rate, protecting against depolarization of the endothelial cell membrane, and reducing free radical production and the renal cell apoptosis rate [32] . Cold ischaemia is not able to prevent cellular injury but only to attenuate it, keeping the metabolic rate at about 10% and in hypoxic conditions: the poor ATP production and the derangement of the Na/K ATPase pump cause cellular swelling and cell-cycle arrest [33] . Experimental studies showed the influence of the duration of cold ischaemia on graft function, suggesting that injury occurs after 6 h of cold ischaemia [34] , but also the effect of the abrupt temperature shift from hypothermia to normothermia on mitochondrial dysfunction and pro-apoptotic [35] . Traditionally, the organs for donation can be procured from living donors or donors after brain-stem death [standard criteria donor (SCD)] in whom the heart is still beating and general blood flow is preserved. Unfortunately, the number of organs available from these donors has never been sufficient [36] . To increase the numbers of available organs in the category of deceased organ donors, two categories have been added: expanded criteria donors (ECD) [37] and DCD [38] . ECD are normally aged 60 years or older, or over 50 years with at least two of the following conditions: hypertension history, serum creatinine (sCr) >1.5 mg/dL and death caused by cerebrovascular accident [37] . ECD transplantation is associated with an increased risk of graft loss compared with transplants from SCD [39] . Mild cooling of the donor from 37 C (60.5 C) to 34.5 C (60.5 C) resulted in a significant reduction in DGF in the transplanted kidneys. In the area of donor management, a recent RCT investigated the effect of mild cooling from 37 C (60.5 C) to 34.5 C (60.5 C) in organ donors after brain death on DGF versus donors subjected to conventional normothermia before organ retrieval. Results showed that DGF occurred in 79/280 (28.2%) recipients in the intervention arm versus 112/286 (39.2%) in the standard arm (P ¼ 0.008), with an impressive difference of about 11% of absolute risk reduction. Although the magnitude of the effect is comparable to HMP studies (compared with cold storage), the recipients were not randomized, and the cold ischaemia times and the warm ischaemia times are not present in significant percentages. The adjusted analysis demonstrates an odds ratio (OR) of 0.62 [95% confidence interval (CI) 0.43-0.92; P-value 0.02] despite correction for covariates, including the cold ischaemia times. The beneficial effect of hypothermia was in particular notable in the ECD group (30% in the intervention versus over 50% in the standard arm). In the SCD group, although hypothermia reduced DGF, this did not reach statistical significance. Nevertheless, the authors did not consider long-term outcomes in their study, such as acute rejection or graft survival, nor outcomes of the other organs transplanted such as livers and pancreases [4] . DCD, defined as organ donation from patients with irremediable brain injuries who do not meet the criteria for brain death testing and who experience cardiopulmonary arrest after withdrawal of ventilator support, has been investigated as a method to increase the number of organs available for donation [38] . The ways in which organ retrieval can take place following circulatory death are described in the modified Maastricht Classification. The first two types are composed of patients who died suddenly on arrival at the Emergency Department (type I) or after an unsuccessful resuscitation (type II). After death declaration, an aortic cannula is placed through the femoral artery and perfusion is started for kidney preservation. Circulation is maintained until the cooling can be performed through the extracorporeal membrane oxygenator and is also combined with a cooler in order to provide cold oxygenated blood to the abdominal visceral organs. With regard to patients dying from CA (type III) or patients with CA while brain death occurs (type IV), after the cessation of the heartbeat, the patient is transferred to the operating room and the kidney is retrieved after in situ cooling. In the case of unexpected CA in a critically ill patient (type V), the management will be the same as for types II and I [40] . DCD renal transplants are accompanied by a greater release of free radicals at reperfusion than SCD and ECD, with an increase in tissue injury markers at reperfusion [41] . DCD organs receive a warm ischaemic insult before the onset of preservation but also a different degree of injury on the basis of the length of ischaemia. For this reason, uncontrolled DCD kidneys are exposed to more prolonged warm ischaemia injury compared with the warm ischaemia time in controlled DCD (15 min) [38] . In addition, the combination of warm ischaemia and cold reperfusion may exacerbate the injury. Although experimental data suggested that the duration of cooling has a strong influence on graft outcome [34] , the direct impact of cold ischaemia on long-term graft survival is less clear.
P O S T -C A R D I A C A R R E S T
The restoration of spontaneous circulation (ROSC) after prolonged, complete, whole-body ischaemia is an unnatural pathophysiological state created by successful cardiopulmonary resuscitation (CPR). The ischaemia and reperfusion during CA, resuscitation and post-resuscitation phases can affect the kidney: the alterations of epithelial cells, interstitial inflammation and interstitial microvasculopathy cause abnormal repair processes, including incomplete repair of tubular cells and fibrosis. The effects of whole-body ischaemia followed by reperfusion activate a systemic inflammatory response and the injury occurs simultaneously in multiple organs through the release of injury products into the circulation associated with defective clearance function after shock [42] . Indeed, after ROSC, AKI is a common complication, with an increase in mortality risk, dialysis requirement and prolonged hospital stay [43] . There is limited information on the epidemiology of AKI after CA, particularly because most studies were performed prior to the development of consensus definitions of AKI. Chua et al. investigated retrospectively the AKI from CA in isolation and AKI secondary to post-CA cardiogenic shock on 105 adult patients who survived for more than 48 h following successful resuscitation after CA. Although baseline sCr levels were not always available and required estimation, results showed that CA in the absence of post-resuscitation cardiogenic shock is uncommonly associated with significant AKI [44] . Geri et al. assessed retrospectively the prevalence of AKI [defined with Acute Kidney Injury Network classification (AKIN)] in 580 CA patients in order to identify risk factors and to evaluate the impact of AKI on outcome after CA. Results showed that AKIN stage 3 was present in 280 (48.3%) patients after CA with a significantly higher association with 30-day mortality. However, urine output was collected within the first 24 h and the urine output criteria were evaluated only on the basis of this data. The admission sCr level was used as a surrogate of baseline characteristics and the estimation of the glomerular filtration rate (GFR) was performed using the modification of diet in renal diseases equation to assess Day-30 GFR, leading to a potential misevaluation of renal recovery [45] . The possibility for a decrease in whole-body temperature, defined as therapeutic hypothermia (TH), could limit the ischaemic injuries. Although there is significant laboratory evidence supporting the efficacy of hypothermia in preserving organ function, the cooling of the whole body for neurological protection in CA patients is challenged by a series of trials that show no benefit [7, 8] , and it remains unclear what therapeutic or harmful effect this could have on renal function because of confounding perturbations in cardiovascular and renal physiology in the post-CA setting [46] . Clinical guidelines suggest that TH increases urine output particularly in the induction phase, and this phenomenon is called cold-induced diuresis (CID) [47] . Debate exists with regard to the significance or impact of CID, the nature of diuresis or the physiological mechanism responsible for CID. One school of thought suggests that CID is a renal autoregulatory response to a relative central hypervolaemia induced by peripheral vasoconstriction with increase in cardiac output and RBF. Other authors think that CID may be due to osmotic alteration (tubular dysfunction) and incapability to appropriately concentrate the urine [47] . Renal function is progressively depressed: a progressive fall in systemic blood pressure causes a decrease in RBF with a consequent rise in renal vascular resistance, promoting a further decrease in RBF and GFR [48] . Only limited human data support the phenomenon of CID. Resuscitation fluids, cardiogenic shock or AKI could influence urine production [49] . Raper et al. performed a secondary analysis of a prospective study on patients receiving TH post CA, observing a modest increase in urine output rates during TH induction compared with the rewarming period. However, they include only a portion of the total TH cases due to the incomplete reporting of urine output. Limited by numerous clinical confounding factors such as body mass index and AKI, the preliminary study supported the evidence of potential CID, but not a rewarm anti-diuresis during TH [47] . Previous trials comparing the effect of TH versus normothermia on kidney endpoints showed conflicting results due to small sample size and low study quality. In the hypothermia after cardiac arrest clinical trial, in all of the patients was observed an increased need for volume replacement due to high urinary output during the cooling period. Results showed no impairment of renal function and no need of haemofiltration, but also no benefits [50] . A meta-analysis [51] including 19 trials suggested that TH, applied in different population settings including brain injury, out-of-hospital CA and major cardiovascular surgery with cardiopulmonary bypass, has no impact on prevention of AKI (OR 1.01; 95% CI 0.68, 1.51; P ¼ 0.95) and dialysis requirement (OR 0.81; 95% CI 0.30, 2.19; P ¼ 0.68), but it was associated with a lower mortality (OR 0.69; 95% CI 0.51, 0.92; P ¼ 0.01). Only one study showed a protective effect of hypothermia against AKI [46] . Unfortunately, most of the trials included were not originally designed to examine the effect of TH on kidney endpoints as their primary endpoint, and the sample sizes were small. In addition, the variability or lack of definition of AKI is evident.
C O N C L U S I O N S
Animal models have been instrumental in defining the pathophysiology of remote organ dysfunction after AKI by reducing the complexity and experimental limitations associated with human studies. Unfortunately, the clinical transfer of experimental results has several limitations particularly because of anatomical and physiological differences. In kidney transplantation, IRI can affect the kidney at various stages and hypothermia represents a double-edged sword: if cold preservation can help against the deleterious effects of ischaemia, a prolonged hypothermia can be associated with worse renal recovery. The relationship between warm ischaemia, cold ischaemia and graft survival is still not clear, although recent evidence showed that the abrupt temperature shift from hypothermia to normothermia could lead to mitochondrial dysfunction and pro-apoptotic signal transduction. In the area of donor management, results from an RCT on application of TH in heart-beating deceased donors showed improvement of short graft outcomes. However, the application of TH for preserving renal function during the donation process could be really helpful also in DCD, in whom there is a greater release of ROS at reperfusion than in a heart-beating donor and living donor, with an increase in tissue injury markers at reperfusion. Data on renal outcomes from TH studies performed to assess neuroprotection in CA evidenced variability or lack of AKI definition. Future studies should address not only the best strategy for gentle rewarming but also the possible application of TH in DCD to preserve renal function during the donation process.
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